PRODUCT OVERVIEW
Linezolid Glucose Injection is presented in the HWTAI product portfolio under Large Volume Parenterals / IV Solutions. The information below keeps the source-verified product identity, dosage form, specifications and packaging details unchanged.
KEY PRODUCT INFORMATION
• Dosage form: Injection
• Specification: 100 mL: Linezolid 0.2 g and glucose (calculated as C6H12O6) 4.57 g
• Packaging: Three-layer co-extruded film for infusion (outer layer: polyester/aluminum/polyethylene pharmaceutical composite film
bag)
B2B PROCUREMENT INFORMATION
For sourcing inquiries, please provide the target market, required specification, packaging preference and estimated order quantity. Availability, lead time, export documentation and market-specific requirements should be confirmed with HWTAI before ordering.
QUALITY AND DOCUMENTATION
Product information is prepared from verified source materials. Applicable batch documents, quality certificates and destination-market documentation can be confirmed during the commercial inquiry process.
FREQUENTLY ASKED QUESTIONS
What specifications are listed?
The source-listed option is: 100 mL: Linezolid 0.2 g and glucose (calculated as C6H12O6) 4.57 g.
How is the product supplied?
Three-layer co-extruded film for infusion (outer layer: polyester/aluminum/polyethylene pharmaceutical composite film
bag).
How can buyers request a quotation?
Send the required specification, quantity, destination market and delivery expectations to HWTAI for a tailored quotation.
IMPORTANT INFORMATION
Final product availability, labeling, packaging and documentation are subject to written commercial and regulatory confirmation.
